title: Is Granulocyte Colony-stimulating Factor Safe in the Treatment of Febrile Neutropenia in Lymphoma Patients with Renal Transplantation?
authors.affiliation: a Medical Oncology Unit , Hacettepe University School of Medicine , Department of Internal Medicine , Ankara , Turkey.
authors.forename: H
authors.initials: H
authors.lastname: Abali
authors.affiliation: b Nephrology Unit , Hacettepe University School of Medicine , Department of Internal Medicine , Ankara , Turkey.
authors.forename: A A
authors.initials: AA
authors.lastname: Kiykim
authors.affiliation: a Medical Oncology Unit , Hacettepe University School of Medicine , Department of Internal Medicine , Ankara , Turkey.
authors.forename: H
authors.initials: H
authors.lastname: Engin
authors.affiliation: a Medical Oncology Unit , Hacettepe University School of Medicine , Department of Internal Medicine , Ankara , Turkey.
authors.forename: N
authors.initials: N
authors.lastname: Güler
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D064147:Febrile Neutropenia / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D016030:Kidney Transplantation; D008223:Lymphoma / Q000188:drug therapy*; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone